Pruitt J Crayton, Lazzara Robert R, Ebra George
Cardiac Surgical Associates MAZE Workgroup, Tampa-Saint Petersburg, FL 33756, USA.
J Interv Card Electrophysiol. 2007 Dec;20(3):83-7. doi: 10.1007/s10840-007-9172-3.
Atrial fibrillation is the most common cardiac rhythm disturbance and is associated with increased morbidity and mortality. It is often found in association with structural heart disease; however, lone atrial fibrillation is not uncommon. Potentially, these patients are ideal candidates for a minimally invasive thoracoscopic approach for the surgical treatment of atrial fibrillation.
From August 2003 through February 2006, 100 drug-resistant symptomatic patients with lone atrial fibrillation underwent thoracoscopic off-pump closed-chest epicardial ablation using the FLEX 10 AFx Microwave Ablation System (Guidant, Indianapolis, IN, USA). There were 66 men (66.0%) and 34 women (34.0%), with a mean age of 60.9 +/- 9.8 (range 37-81) years. Mean duration of atrial fibrillation was 72.4 +/- 79.5 (range 6-480) months. Sixty-four patients (64.0% had paroxysmal, 11 (11.0%) had persistent and 25 (25.0%) had permanent atrial fibrillation.
There were no hospital deaths. Postoperative in-hospital complications were minimal. Mean postoperative length of stay was 3.4 +/- 1.7 days. Cumulative follow-up was 2,106.3 (mean 23.1) patient months, with a maximum follow-up of 39.8 months. There were three late deaths (3.0%). In nine patients (9.0%), the thoracoscopic box lesion pulmonary vein isolation operation and subsequent electrophysiological intervention failed, and a Cox-Maze operation was performed. Follow-up was 100% complete, with 42.0% (37 of 88) patients in normal sinus rhythm. Two patients (2.3%) experienced a transient ischemic attack and two (2.3%) a cerebral vascular accident. Twenty-seven patients (30.7%) required electrophysiological intervention post procedure. Ten patients (11.4%) were on amiodarone and 48 (54.5%) were on coumadin at follow-up.
Totally thoracoscopic surgical ablation for the treatment of atrial fibrillation is technically feasible and presents minimal risk to the patient. Clinical results with the application of microwave energy have been less than satisfactory, with no demonstrated electrical isolation of the pulmonary veins. Moreover, long-term relief from atrial fibrillation has not been achieved.
心房颤动是最常见的心律失常,与发病率和死亡率增加相关。它常与结构性心脏病相关;然而,孤立性心房颤动也并不少见。潜在地,这些患者是采用微创胸腔镜方法手术治疗心房颤动的理想候选人。
从2003年8月至2006年2月,100例有症状的药物难治性孤立性心房颤动患者使用FLEX 10 AFx微波消融系统(美国印第安纳波利斯市的Guidant公司)接受了胸腔镜非体外循环闭式心包外膜消融术。其中男性66例(66.0%),女性34例(34.0%),平均年龄60.9±9.8(范围37 - 81)岁。心房颤动的平均持续时间为72.4±79.5(范围6 - 480)个月。64例患者(64.0%)为阵发性心房颤动,11例(11.0%)为持续性心房颤动,25例(25.0%)为永久性心房颤动。
无住院死亡病例。术后住院并发症极少。术后平均住院时间为3.4±1.7天。累积随访时间为2106.3(平均23.1)患者月,最长随访时间为39.8个月。有3例晚期死亡(3.0%)。9例患者(9.0%)胸腔镜盒状病变肺静脉隔离手术及随后的电生理干预失败,改行Cox迷宫手术。随访完全率为100%,42.0%(88例中的37例)患者恢复正常窦性心律。2例患者(2.3%)发生短暂性脑缺血发作,2例(2.3%)发生脑血管意外。27例患者(30.7%)术后需要电生理干预。随访时10例患者(11.4%)服用胺碘酮,48例(54.5%)服用华法林。
完全胸腔镜手术消融治疗心房颤动在技术上是可行的,对患者的风险极小。应用微波能量的临床结果并不理想,未实现肺静脉的电隔离。此外,尚未实现心房颤动的长期缓解。